Title:
抗ＩＬ－１７Ａ／Ｆ抗体を用いた治療方法
Document Type and Number:
Japanese Patent JP7176044
Kind Code:
B2
Abstract:
The invention relates to therapeutic uses of antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F in the treatment of dermatological and rheumatological diseases, such as psoriasis, psoriatic arthritis and axial spondyloarthritis.
More Like This:
| JP2012021010 | METHOD FOR MODULATING INFLAMMATORY RESPONSE |
| JP2023527563 | Method for treating IgA nephropathy with APRIL-binding antibody |
| WO/2007/102200 | ANTI-CD20 MONOCLONAL ANTIBODY |
Inventors:
Glatt, Sophie
Ionescu, Lucian
Jones, Margaret
Oliver, Ruth
Shaw, Stevan Graham
Strymenopoul, Fotini
Vajjaa, Venkata Pavan Kumar
Ionescu, Lucian
Jones, Margaret
Oliver, Ruth
Shaw, Stevan Graham
Strymenopoul, Fotini
Vajjaa, Venkata Pavan Kumar
Application Number:
JP2021092630A
Publication Date:
November 21, 2022
Filing Date:
June 01, 2021
Export Citation:
Assignee:
UCB Biopharma SRL
International Classes:
A61K39/395; A61P19/02; A61P29/00; A61P37/06
Domestic Patent References:
| JP2014505474A |
Attorney, Agent or Firm:
Patent Attorney Corporation Asamura Patent Office